Product Information
NALOXONE HCL 4 MG NASAL SPRAY is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $17.1773 per EA under NDC 60219210407. Its NADAC has been published 98 times since Nov 20, 2024.
FDA first approved this application on Apr 23, 2024.
Strength
4 mg/.1mL
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
60219210407
Classification
Generic
Dosage Form
SPRAY
Route
NASAL
Effective Date
9/23/2026
Active Ingredients
NALOXONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA217992FDA Approved
4/23/2024
On Market Since
4/24/2024
Pharmacological Classes
Price Statistics
The NADAC for NALOXONE HCL 4 MG NASAL SPRAY has been published 98 times since Nov 20, 2024, and over the history we have for it it has declined 34.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $17.1773 per EA |
|---|---|
| All-time high | $29.0372 (Apr 16, 2025) |
| All-time low | $15.2248 (May 20, 2026) |
| 52-week high | $22.8128 |
| 52-week low | $15.2248 |
| Median price | $22.8034 |
| Average price | $21.3288 |
| Largest weekly change | -32.4% (Nov 19, 2025) |
| Weeks tracked | 98 |
| Tracking since | Nov 20, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Naloxone market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals NY LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Naloxone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NALOXONE HCL 4 MG NASAL SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for NALOXONE HCL 4 MG NASAL SPRAY, manufactured by Amneal Pharmaceuticals NY LLC, is $17.1773 per EA (NDC 60219210407), effective Sep 30, 2026.
How has the price of NALOXONE HCL 4 MG NASAL SPRAY changed over time?
Over the history we have for it, the NADAC for NALOXONE HCL 4 MG NASAL SPRAY has declined 34.1%. It has been tracked across 98 weekly CMS publications since Nov 20, 2024.
What are the highest and lowest recorded NADAC prices for NALOXONE HCL 4 MG NASAL SPRAY?
Since Nov 20, 2024, the NADAC for NALOXONE HCL 4 MG NASAL SPRAY has ranged from a low of $15.2248 (May 20, 2026) to a high of $29.0372 (Apr 16, 2025), with a median of $22.8034 per EA.
Are there cheaper alternatives to NALOXONE HCL 4 MG NASAL SPRAY?
No other NADAC-published product currently shares the active ingredient and strength of NALOXONE HCL 4 MG NASAL SPRAY in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NALOXONE HCL 4 MG NASAL SPRAY?
NALOXONE HCL 4 MG NASAL SPRAY (NDC 60219210407) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.